GlassScriptPhysician profile
Jeff Thomas Marlor
NPI 1710473814
$1,364.04
in general payments reported to CMS, 2019-2025
9 companies · $64.48 in 2025
The $64.48 reported for 2025 was less than what a typical General Practice (Dentist) provider received nationally (typical 2025 total: $74.60).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $35.00 · 2020: $222 · 2021: $178 · 2022: $458 · 2023: $176 · 2024: $231 · 2025: $64.48.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $472.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $471.58 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Align Technology, INC. | $551.89 | 2020-2025 | Invisalign |
| Planmeca USA, INC. | $433.65 | 2022 | |
| Straumann USA LLC | $185.19 | 2024 | |
| Dentsply Sirona INC | $73.69 | 2022-2023 | Astra Tech Implant System, Tph Spectra Universal Composite Restorative Low Viscosity, Palodent Plus Ez Coat Sectional Matrix System |
| Premier Dental Products Company | $35.00 | 2019 | |
| Biolase, INC. | $30.93 | 2023 | Waterlase Iplus |
| Merck Sharp & Dohme LLC | $24.47 | 2025 | Bridion |
| Philips North America LLC | $17.06 | 2023 | |
| Dmg America LLC | $12.16 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jeff Marlor listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.